Ozempic DualDose 0.25 mg / 0.5 mg
Ozempic DualDose 0.25 mg / 0.5 mg is a medicine authorised by Swissmedic under authorisation number 66604. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 July 2018 and the authorisation is valid without a time limit. ATC code A10BJ06 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 66604 |
|---|---|
| Name | Ozempic DualDose 0.25 mg / 0.5 mg |
| Full name | Ozempic DualDose 0.25 mg / 0.5 mg, Fertigpen (1.34 mg/ml) |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10BJ06 |
| First authorisation | 02 July 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ozempic DualDose 0.25 mg / 0.5 mg, Fertigpen (1.34 mg/ml) | B | 02 July 2018 |
| 2 | Ozempic FixDose 1 mg, Fertigpen (1.34 mg/ml) | B | 02 July 2018 |
| 3 | Ozempic FixDose 2 mg, Fertigpen | B | 14 September 2021 |
| 4 | Ozempic FixDose 1 mg, Fertigpen (2.68 mg/ml) | B | 01 July 2026 |
| 5 | Ozempic DualDose 0.25 mg / 0.5 mg, Fertigpen (0.68 mg/ml) | B | 29 July 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 x 1,5 | ml | A10BJ06 | 07.06. | B |
| 6 | 1 x 3 | ml | A10BJ06 | 07.06. | B |
| 3 | 1 x 3 | ml | A10BJ06 | 07.06. | B |
| 4 | 1 x 3 | ml | A10BJ06 | 07.06. | B |
| 5 | 1 x 3 | ml | A10BJ06 | 07.06. | B |
| 7 | 1 x 3 | ml | A10BJ06 | 07.06. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ozempic DualDose 0.25 mg / 0.5 mg authorised in Switzerland?
Yes. Ozempic DualDose 0.25 mg / 0.5 mg is authorised by Swissmedic under authorisation number 66604, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ozempic DualDose 0.25 mg / 0.5 mg have?
Ozempic DualDose 0.25 mg / 0.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ozempic DualDose 0.25 mg / 0.5 mg?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.